跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,244 条关于
“MAPK/ERK”
全部
3,244
临床试验
2,516
药物
292
机构
25
资讯
411
8个月前
BEAVER Trial Demonstrates Efficacy of Binimetinib-Encorafenib Combination in Advanced Non-V600E BRAF-Mutated Tumors
去年
CTC-Guided EGFR Inhibitor Therapy Achieves 14-Month Response in Metastatic Hepatocellular Carcinoma
16天前
Tumor-Associated Macrophages Emerge as Central Drivers of Gastric Cancer Peritoneal Metastasis and Immunotherapy Resistance
8个月前
Verastem Discontinues KRAS G12C Trial to Focus on Promising G12D Inhibitor with 69% Response Rate
去年
Pegmolesatide Shows Promise as Long-Acting Anemia Treatment in Phase II Trials for CKD Patients
去年
Neurofibromatoses Pipeline Shows Strong Activity with 12+ Therapies in Development Across Multiple Clinical Stages
2年前
Pasithea Therapeutics Announces FDA Acceptance of IND Application for PAS-004 in Advanced Cancer Patients
去年
Pasithea's PAS-004 Shows Strong Target Engagement with 91% pERK Inhibition in Phase 1 Cancer Trial
8个月前
Derazantinib Enhances Gemcitabine Efficacy in Pancreatic Cancer by Suppressing NF-κB and MAPK Pathways
去年
PAS-004 Shows Favorable Safety and Early Efficacy in MAPK-Driven Solid Tumors
第 1 页,共 42 页
上一页
下一页